GAL and Alzheimer disease: In the former case, a nano-system comprising a cationic polymeric carrier, namely chitosan (CS), and GAL, was evaluated, while Bhattacharya and coworkers investigated the alleviation of AD symptoms in mice by intranasally administering a pro-drug form of GLN (i.e., memogain).